Search Results - "Knoop, AS" :: K.UTB vyhledávací portál

Loading…

Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors

by Eckhoff, L, Knoop, AS, Jensen, MB, Ewertz, M
Published in European journal of cancer (1990) (01.02.2015)

Get full text

Journal Article

Loading…

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

by KNOOP, Ann S, KNUDSEN, Helle, EJLERTSEN, Bent, BALSLEV, Eva, RASMUSSEN, Birgitte B, OVERGAARD, Jens, NIELSEN, Kirsten V, SCHONAU, Andreas, GUNNARSDOTTIR, Katrin, OLSEN, Karen E, MOUNDSEN, Henning
Published in Journal of clinical oncology (20.10.2005)

Get full text

Journal Article

Loading…

Abstract P2-08-10: Validation of prediction of local recurrence (LR) by Prosigna® (PAM50) in a Danish breast cancer cooperative group (DBCG) cohort of hormone receptor positive (HR+), postmenopausal early breast cancer (EBC) patients allocated to 5yr of endocrine therapy (ET)

by Ole Eriksen, J, Jensen, M-B, Laenkholm, A-V, Kibøll, T, Bruun Rasmussen, B, Knoop, AS, Ferree, S, Haffner, T, Buckingham, W, Schaper, C, Ejlertsen, B
Published in Cancer research (Chicago, Ill.) (15.02.2016)

Get full text

Journal Article

Loading…

Abstract P1-13-03: ER, PR, HER2, and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial

by Knoop, AS, Lænkholm, A-V, Jensen, M-B, Nielsen, KV, Andersen, J, Nielsen, D, Ejlertsen, B
Published in Cancer research (Chicago, Ill.) (15.12.2013)

Get full text

Journal Article

Loading…

Abstract S6-03: DBCG 07-READ: A randomized phase III trial comparing six cycles of docetaxel and cyclophosphamide (DC) to three cycles of epirubicin and cyclophosphamide followed by three cycles of docetaxel (EC-D) in patients with early breast cancer

by Ejlertsen, B, Tuxen, MK, Jakobsen, EH, Jensen, M-B, Knoop, AS, Hoejris, I, Ewertz, M, Balslev, E, Vestlev, PM, Kenholm, J, Nielsen, DL, Bechmann, T, Andersson, M, Cold, S, Nielsen, HM, Maae, E, Carlsen, D, Mouridsen, HT
Published in Cancer research (Chicago, Ill.) (15.02.2017)

Get full text

Journal Article

Loading…

Abstract P4-08-01: ESR1 Gene Aberrations Correlate with ER Protein Levels Measured by DCC and IHC

by Lænkholm, A-V, Nielsen, KV, Knoop, AS, Müller, S, Rasmussen, BB, Ejlertsen, B.
Published in Cancer research (Chicago, Ill.) (15.12.2010)

Get full text

Journal Article

Loading…

Value of Epidermal Growth Factor Receptor, HER2, p53, and Steroid Receptors in Predicting the Efficacy of Tamoxifen in High-Risk Postmenopausal Breast Cancer Patients

by KNOOP, Ann S, BENTZEN, Siren M, NIELSEN, Mette M, RASMUSSEN, Birgitte B, ROSE, Carsten
Published in Journal of clinical oncology (15.07.2001)

Get full text

Journal Article

Loading…

TOP2A , TIMP-1 and responsiveness to adjuvant anthracycline containing chemotherapy in high risk breast cancer patients

by Ejlertsen, B, Jensen, M, Nielsen, KV, Balslev, E, Willemoe, GL, Hertel, PB, Knoop, AS, Mouridsen, HT, Brünner, N
Published in Cancer research (Chicago, Ill.) (15.01.2009)

Get full text

Journal Article